AR and prostate carcinoma: Our results indicate that the interaction between PAK6 and AR is responsible, at least in part, for the activation of PAK6 in prostate cancer cells in response to androgen stimulation since knock-down of AR expression by AR-specific siRNA in LAPC4 cells downregulates androgen-stimulated PAK6 activation.